Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 08, 2026)


SHSE:688621 Beijing Sun-Novo Pharmaceutical Research Co Ltd SHSE:688621
85 GF Score
Price ¥49.10
GF Value ¥69.90
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Beijing Sun-Novo Pharmaceutical Research Co Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Beijing Sun-Novo Pharmaceutical Research Co's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SHSE:688621 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Sun-Novo Pharmaceutical Research Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Sun-Novo Pharmaceutical Research Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Sun-Novo Pharmaceutical Research Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Beijing Sun-Novo Pharmaceutical Research Co's Margin of Safety % (DCF Earnings Based) falls into.


SHSE:688621
85GF Score
Beijing Sun-Novo Pharmaceutical Research Co Ltd SHSE:688621
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Sun-Novo Pharmaceutical Research Co (SHSE:688621) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Sun-Novo Pharmaceutical Research Co stock appears to be undervalued. The current stock price of ¥49.10 is trading 29.8% below its estimated GF Value™ of ¥69.90. GuruFocus considers Beijing Sun-Novo Pharmaceutical Research Co to be Significantly Undervalued.

Key valuation signals for SHSE:688621:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ¥69.90 vs. price of ¥49.10 (29.8% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688621 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Sun-Novo Pharmaceutical Research Co Business Description

Address No. 79 Shuangying West Road, 1st Floor, Building 7, Science Park, Changping District, Beijing, CHN, 102200
Beijing Sun-Novo Pharmaceutical Research Co Ltd is engaged in providing professional research and development outsourcing services for pharmaceutical companies.
85GF Score

Get the complete analysis for SHSE:688621

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥49.10
Price
¥69.90
GF Value